GP | MIN | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | OREB | DREB | REB | AST | TOV | STL | BLK | PF | DD2 | TD3 | PTS | +/- |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
73 | 2297 | 398 | 716 | 0.556% | 40 | 138 | 0.29% | 177 | 269 | 0.658% | 174 | 297 | 471 | 259 | 105 | 56 | 45 | 142 | 0 | 0 | 1013 | 0 |
GP | MIN | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | OREB | DREB | REB | AST | TOV | STL | BLK | PF | DD2 | TD3 | PTS | +/- |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
61 | 1784 | 312 | 649 | 0.48% | 62 | 194 | 0.32% | 133 | 194 | 0.69% | 107 | 277 | 384 | 161 | 90 | 45 | 39 | 120 | 0 | 0 | 819 | 0 |
SEASON | TEAM | GP | MIN | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | OREB | DREB | REB | AST | TOV | STL | BLK | PF | DD2 | TD3 | PTS | +/- |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | DEN | 73 | 2297 | 398 | 716 | 0.556% | 40 | 138 | 0.29% | 177 | 269 | 0.658% | 174 | 297 | 471 | 259 | 105 | 56 | 45 | 142 | 0 | 0 | 1013 | 0 |
2022 | DEN | 68 | 2055 | 429 | 761 | 0.564% | 60 | 173 | 0.347% | 191 | 314 | 0.608% | 164 | 282 | 446 | 203 | 98 | 54 | 51 | 129 | 0 | 0 | 1109 | 0 |
2021 | DEN | 75 | 2375 | 434 | 834 | 0.52% | 87 | 260 | 0.335% | 171 | 230 | 0.743% | 125 | 314 | 439 | 188 | 133 | 44 | 44 | 148 | 0 | 0 | 1126 | 0 |
2020 | DEN | 25 | 648 | 103 | 206 | 0.5% | 17 | 64 | 0.266% | 31 | 44 | 0.705% | 38 | 80 | 118 | 56 | 30 | 17 | 14 | 40 | 0 | 0 | 254 | 0 |
2020 | ORL | 25 | 736 | 128 | 293 | 0.437% | 42 | 112 | 0.375% | 66 | 105 | 0.629% | 39 | 127 | 166 | 105 | 67 | 16 | 20 | 49 | 0 | 0 | 364 | 0 |
2019 | ORL | 62 | 2017 | 335 | 767 | 0.437% | 73 | 237 | 0.308% | 151 | 224 | 0.674% | 107 | 368 | 475 | 228 | 100 | 51 | 39 | 125 | 0 | 0 | 894 | 0 |
2018 | ORL | 78 | 2633 | 470 | 1046 | 0.449% | 121 | 347 | 0.349% | 185 | 253 | 0.731% | 129 | 445 | 574 | 289 | 162 | 57 | 56 | 172 | 0 | 0 | 1246 | 0 |
2017 | ORL | 58 | 1909 | 375 | 865 | 0.434% | 115 | 342 | 0.336% | 157 | 225 | 0.698% | 87 | 370 | 457 | 136 | 107 | 59 | 45 | 111 | 0 | 0 | 1022 | 0 |
2016 | ORL | 80 | 2298 | 393 | 865 | 0.454% | 77 | 267 | 0.288% | 156 | 217 | 0.719% | 116 | 289 | 405 | 150 | 89 | 65 | 40 | 172 | 0 | 0 | 1019 | 0 |
2015 | ORL | 78 | 1863 | 274 | 579 | 0.473% | 42 | 142 | 0.296% | 129 | 193 | 0.668% | 154 | 353 | 507 | 128 | 66 | 59 | 55 | 153 | 0 | 0 | 719 | 0 |
2014 | ORL | 47 | 797 | 93 | 208 | 0.447% | 13 | 48 | 0.271% | 44 | 61 | 0.721% | 46 | 123 | 169 | 33 | 38 | 21 | 22 | 83 | 0 | 0 | 243 | 0 |